title: The impaired fibrinolytic capacity in hypertension is unaffected by acute blood pressure lowering.
abstract: The endogenous fibrinolytic system and the ability of the endothelium to release tissue-plasminogen activator (t-PA) play a pivotal role to protect humans from atherothrombotic events. We have recently reported that the decreased capacity for t-PA release in hypertension is restored with chronic blood pressure lowering. Thus, we explored if acute blood pressure lowering has the same effect. The capacity for acute t-PA release was investigated in the perfused-forearm model during stimulation by intra-arterial substance P 8 pmol/min in hypertensive subjects. The procedure was then repeated during acute blood pressure lowering (n = 9) induced by sodium nitroprusside (SNP) infusion or during placebo infusion (n = 3). SNP lowered mean arterial pressure from 108.6 (2.6) to 83.0 (2.6) (mean and SEM) mmHg (P < 0.001). Substance P induced significant increase in t-PA release during both high- and low-pressure conditions (P < 0.01, ANOVA). Peak t-PA release rate was 199 (77) and 167 (41) (mean and SEM) ng/min/l tissue, and accumulated t-PA release was 2,395 (750) and 2,394 (473) ng, during high- and low-pressure conditions, respectively. t-PA release and hemodynamic responses were almost identical during high- and low-pressure conditions (P = ns, for all). Acute blood pressure lowering does not restore stimulated t-PA release from the endothelium in hypertensive subjects. These findings are in contrast to previously described effects of chronic blood pressure treatment. Although data need to be confirmed in a larger study, they suggest that high blood pressure decreases the cellular t-PA pool rather than interferes with release mechanisms of the protein.
authors: The Wallenberg Laboratory for Cardiovascular Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
authors: Wilhelm
authors: W
authors: Ridderstråle
authors: Ott
authors: O
authors: Saluveer
authors: Maria
authors: M
authors: Carlström
authors: Sverker
authors: S
authors: Jern
authors: Thórdís J
authors: TJ
authors: Hrafnkelsdóttir
references: Circulation. 2000 Apr 4;101(13):1594-7
references: 10747354
references: Hypertension. 2007 Apr;49(4):878-84
references: 17339540
references: Circulation. 2000 Oct 31;102(18):2190-6
references: 11056091
references: Thromb Haemost. 1997 Oct;78(4):1242-8
references: 9364992
references: N Engl J Med. 1980 Oct 16;303(16):897-902
references: 7412821
references: Biochem Biophys Res Commun. 2009 Feb 6;379(2):532-6
references: 19116134
references: Hypertension. 2000 Apr;35(4):1002-8
references: 10775576
references: Thromb Haemost. 2007 Aug;98(2):420-6
references: 17721626
references: J Physiol. 2003 Sep 1;551(Pt 2):721-8
references: 12815179
references: Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1651-6
references: 17463331
references: Hypertension. 2006 Apr;47(4):686-91
references: 16520399
references: Free Radic Biol Med. 2008 Feb 1;44(3):315-21
references: 18215739
references: Blood. 1998 Jan 15;91(2):529-37
references: 9427706
references: Hypertension. 2004 Sep;44(3):300-4
references: 15249548
references: Circulation. 2000 Jan 25;101(3):218-20
references: 10645912
references: Cardiovasc Res. 1998 May;38(2):485-92
references: 9709410
references: Lancet. 1998 Nov 14;352(9140):1597-8
references: 9843110
references: Ann N Y Acad Sci. 1992 Dec 4;667:249-58
references: 1309043
references: Lancet. 1990 Apr 7;335(8693):827-38
references: 1969567
references: Hypertension. 2008 Aug;52(2):314-21
references: 18574075
references: J Hypertens. 2005 Aug;23(8):1551-7
references: 16003182
references: J Pharmacol Exp Ther. 2010 Jan;332(1):291-7
references: 19841473
references: Thromb Haemost. 1989 Jun 30;61(3):409-14
references: 2508254